{"name":"Instituto de Investigacion Sanitaria La Fe","slug":"instituto-de-investigacion-sanitaria-la-fe","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Bravelle","genericName":"Bravelle","slug":"bravelle","indication":"Other","status":"marketed"},{"name":"Ganirelix 0.25 mg.","genericName":"Ganirelix 0.25 mg.","slug":"ganirelix-0-25-mg","indication":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART) procedures","status":"phase_3"},{"name":"Micronized natural progesterone.","genericName":"Micronized natural progesterone.","slug":"micronized-natural-progesterone","indication":"Endometrial protection in hormone replacement therapy","status":"phase_3"},{"name":"Recombinant choriogonadotropin alfa","genericName":"Recombinant choriogonadotropin alfa","slug":"recombinant-choriogonadotropin-alfa","indication":"Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"A (Chloraprep)","genericName":"A (Chloraprep)","slug":"a-chloraprep","indication":"Skin antisepsis prior to surgery or invasive procedures","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"B (Clorhexidine 2%)","genericName":"B (Clorhexidine 2%)","slug":"b-clorhexidine-2","indication":"Oral antisepsis and plaque control","status":"marketed"}]}],"pipeline":[{"name":"A (Chloraprep)","genericName":"A (Chloraprep)","slug":"a-chloraprep","phase":"marketed","mechanism":"Chloraprep is an antimicrobial skin antiseptic that kills bacteria and other microorganisms on the skin surface through oxidative damage.","indications":["Skin antisepsis prior to surgery or invasive procedures","Skin preparation for central venous catheter insertion","General skin antisepsis and wound cleansing"],"catalyst":""},{"name":"Bravelle","genericName":"Bravelle","slug":"bravelle","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"B (Clorhexidine 2%)","genericName":"B (Clorhexidine 2%)","slug":"b-clorhexidine-2","phase":"marketed","mechanism":"Chlorhexidine is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, leading to rapid bactericidal and bacteriostatic effects.","indications":["Oral antisepsis and plaque control","Skin antisepsis and wound disinfection","Mucous membrane disinfection"],"catalyst":""},{"name":"Ganirelix 0.25 mg.","genericName":"Ganirelix 0.25 mg.","slug":"ganirelix-0-25-mg","phase":"phase_3","mechanism":"Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist that suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion to prevent premature ovulation during assisted reproductive procedures.","indications":["Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART) procedures"],"catalyst":""},{"name":"Micronized natural progesterone.","genericName":"Micronized natural progesterone.","slug":"micronized-natural-progesterone","phase":"phase_3","mechanism":"Micronized natural progesterone binds to progesterone receptors throughout the body to exert hormonal effects on the endometrium, breast, and other reproductive tissues.","indications":["Endometrial protection in hormone replacement therapy","Luteal phase support / progesterone supplementation","Menopause-related symptoms"],"catalyst":""},{"name":"Recombinant choriogonadotropin alfa","genericName":"Recombinant choriogonadotropin alfa","slug":"recombinant-choriogonadotropin-alfa","phase":"phase_3","mechanism":"Recombinant choriogonadotropin alfa (hCG) is a recombinant human chorionic gonadotropin that stimulates ovarian follicle development and triggers final oocyte maturation in assisted reproductive technology.","indications":["Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles","Controlled ovarian hyperstimulation in infertility treatment"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":6,"phaseCounts":{"marketed":3,"phase_3":3},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}